| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 117,455 | 90,032 | 74,981 | 55,837 | | Cost of Revenue | 472 | 435 | 392 | 631 | | | Gross Profit | 116,983 | 89,597 | 74,589 | 55,206 | | | Operating Expenses | | Research Development | 105,434 | 92,392 | 82,146 | 76,314 | | Selling General and Administrative | 12,840 | 11,378 | 11,674 | 13,491 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (1,291) | (14,173) | (19,231) | (34,599) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 857 | 1,328 | 1,750 | 2,648 | | Earnings Before Interest And Taxes | (434) | (12,845) | (17,481) | (31,951) | | Interest Expense | 581 |
-
|
-
| 295 | | Income Before Tax | (1,015) | (12,845) | (17,481) | (32,246) | | Income Tax Expense |
-
|
-
|
-
| (728) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (1,015) | (12,845) | (17,481) | (31,518) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (1,015) | (12,845) | (17,481) | (31,518) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($1,015) | ($12,845) | ($17,481) | ($31,518) |
|
0.31% Nasdaq 
0.05%
Income Statement
